EGFR-expressing glioma cells exhibit increased glutamate export, cystine uptake, and GSH biosynthesis, while targeted inhibition of SLC7A11 suppresses the antioxidant capacity, growth, and invasion of EGFR-overexpressing cancer cells. The gene discussed is EGFR; the disease is cancer.